Immunoassay Market 2024-2032: Industry Size, Share, Growth Opportunities, Forecast
According to the latest report by IMARC Group, titled “Immunoassay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on immunoassay market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market.
The global immunoassay market size reached US$ 31.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 49.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.
An immunoassay is a laboratory technique used to detect and quantify specific substances in biological samples based on the interaction between an antigen and an antibody. It involves the use of antibodies or antigens labeled with a detectable marker, such as a fluorescent dye or enzyme, to identify and measure the target analyte. Immunoassays are widely utilized in medical diagnostics, pharmaceutical research, and environmental monitoring to detect hormones, proteins, drugs, infectious agents, and other biomolecules. They offer high sensitivity, specificity, and versatility, making them valuable tools for diagnosing diseases, monitoring treatment efficacy, and conducting scientific research in various fields of medicine and biotechnology.
Request to Get the Sample Report: https://www.imarcgroup.com/immunoassay-market/requestsample
Market Trends:
The global market is majorly driven by the increasing prevalence of chronic and infectious diseases. Immunoassays offer high sensitivity and specificity, making them valuable tools for diagnosing conditions such as cancer, infectious diseases, autoimmune disorders, and cardiac biomarkers. Technological advancements in immunoassay platforms, such as automated systems, multiplexing capabilities, and improved detection methods, are driving market growth. These innovations enhance assay performance, reduce turnaround time, and increase throughput, meeting the growing demand for rapid and accurate diagnostic solutions. Moreover, the expanding applications of immunoassays in drug development, clinical research, and biotechnology are driving market expansion. Immunoassays play a crucial role in drug discovery, pharmacokinetics, and biomarker identification, contributing to the development of novel therapeutics and personalized medicine approaches. Additionally, favorable regulatory policies and initiatives aimed at improving healthcare infrastructure and access to diagnostic services in emerging economies are driving market growth. Governments and healthcare organizations are investing in expanding diagnostic capabilities and implementing screening programs, further boosting demand for immunoassay technologies. Furthermore, the increasing adoption of point-of-care testing and decentralized testing solutions is driving market expansion. Immunoassay platforms suitable for use in non-laboratory settings offer convenience, accessibility, and rapid results, addressing the need for efficient diagnostic solutions in diverse healthcare settings.
Explore Full Report with Table of Contents: https://www.imarcgroup.com/immunoassay-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott
Becton Dickinson and Company
BioMérieux SA
Danaher Corporation
Merck KGaA
PerkinElmer Inc
Quidel Corporation
Siemens Healthcare Pty Ltd (Siemens AG)
Sysmex Corporation
Thermo Fisher Scientific
Immunoassay Market Segmentation:
Our report has categorized the market based on region, technology, product, application and end use.
Breakup by Technology:
Radioimmunoassay
Enzyme Immunoassay
Rapid Test
Others
Breakup by Product:
Reagents and Kits
Analyzers/Instruments
Software and Services
Breakup by Application:
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease Testing
Autoimmune Diseases
Others
Breakup by End Use:
Hospitals
Blood Banks
Clinical Laboratories
Pharmaceutical and Biotech Companies
Academic Research Centers
Others
Breakup by Region:
North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
Market Performance (2018-2023)
Market Outlook (2024-2032)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group134 N 4th St. Brooklyn, NY 11249, USAEmail: [email'protected]Tel No:(D) +91 120 433 0800United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
